Latest ACUTA CAPITAL PARTNERS, LLC Stock Portfolio
ACUTA CAPITAL PARTNERS, LLC Performance:
2024 Q4: -2.22%YTD: 28.34%2023: 7.39%
Performance for 2024 Q4 is -2.22%, and YTD is 28.34%, and 2023 is 7.39%.
About ACUTA CAPITAL PARTNERS, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ACUTA CAPITAL PARTNERS, LLC reported an equity portfolio of $99.4 Millions as of 31 Dec, 2024.
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are OCUL, INSM, . The fund has invested 9.5% of it's portfolio in OCULAR THERAPEUTIX INC and 7.3% of portfolio in INSMED INC.
The fund managers got completely rid off KURA ONCOLOGY INC. COMMON STOCK (KURA), COMPASS PATHWAYS PLC (CMPS) and ACELYRIN INC stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), VAXCYTE INC (PCVX) and TAYSHA GENE THERAPIES INC (TSHA). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in BRIGHT MINDS BIOSCIENCES INC, CIDARA THERAPEUTICS INC (CDTX) and NEWAMSTERDAM PHARMA CO NV (NAMS). The fund showed a lot of confidence in some stocks as they added substantially to THIRD HARMONIC BIO INC (THRD), TREVI THERAPEUTICS INC (TRVI) and TECTONIC THERAPEUTIC INC.
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are OCUL, INSM, . The fund has invested 9.5% of it's portfolio in OCULAR THERAPEUTIX INC and 7.3% of portfolio in INSMED INC.
The fund managers got completely rid off KURA ONCOLOGY INC. COMMON STOCK (KURA), COMPASS PATHWAYS PLC (CMPS) and ACELYRIN INC stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), VAXCYTE INC (PCVX) and TAYSHA GENE THERAPIES INC (TSHA). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in BRIGHT MINDS BIOSCIENCES INC, CIDARA THERAPEUTICS INC (CDTX) and NEWAMSTERDAM PHARMA CO NV (NAMS). The fund showed a lot of confidence in some stocks as they added substantially to THIRD HARMONIC BIO INC (THRD), TREVI THERAPEUTICS INC (TRVI) and TECTONIC THERAPEUTIC INC.
ACUTA CAPITAL PARTNERS, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that ACUTA CAPITAL PARTNERS, LLC made a return of -2.22% in the last quarter. In trailing 12 months, it's portfolio return was 28.34%.
New Buys
| Ticker | $ Bought |
|---|---|
| bright minds biosciences inc | 2,489,850 |
| cidara therapeutics inc | 1,464,230 |
| newamsterdam pharma co nv | 1,285,000 |
| zymeworks inc | 984,394 |
| eledon pharmaceuticals inc | 971,290 |
| sangamo therapeutics inc | 754,800 |
| forte biosciences inc | 411,937 |
| corvus pharmaceuticals inc | 397,542 |
New stocks bought by ACUTA CAPITAL PARTNERS, LLC
Additions
| Ticker | % Inc. |
|---|---|
| third harmonic bio inc | 221 |
| trevi therapeutics inc | 165 |
| tectonic therapeutic inc | 140 |
| liquidia corporation | 87.36 |
| edgewise therapeutics inc | 39.14 |
| praxis precision medicines i | 17.39 |
| argenx se | 17.12 |
| unicycive therapeutics inc | 16.36 |
Additions to existing portfolio by ACUTA CAPITAL PARTNERS, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| arcellx inc | -82.7 |
| vaxcyte inc | -66.77 |
| taysha gene therapies inc | -58.27 |
| gilead sciences inc | -53.08 |
| celcuity inc | -46.35 |
| mereo biopharma group pl-adr | -38.18 |
| rocket pharmaceuticals inc | -29.21 |
| ultragenyx pharmaceutical inc | -16.33 |
ACUTA CAPITAL PARTNERS, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| compass pathways plc | -2,434,950 |
| acelyrin inc | -1,794,520 |
| kura oncology inc. common stock | -3,849,380 |
| geron corp | -703,246 |
| leap therapeutics inc | -309,685 |
| climb bio inc | -274,860 |
| dyne therapeutics inc | -1,659,500 |
| benitec biopharma inc | -273,862 |
ACUTA CAPITAL PARTNERS, LLC got rid off the above stocks
Sector Distribution
ACUTA CAPITAL PARTNERS, LLC has about 71.6% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 71.6 |
| Others | 28.4 |
Market Cap. Distribution
ACUTA CAPITAL PARTNERS, LLC has about 8.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 32.4 |
| SMALL-CAP | 26.3 |
| MID-CAP | 16.7 |
| MICRO-CAP | 8.4 |
| LARGE-CAP | 8.1 |
| NANO-CAP | 8.1 |
Stocks belong to which Index?
About 55% of the stocks held by ACUTA CAPITAL PARTNERS, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 55 |
| Others | 44.2 |
ACUTA CAPITAL PARTNERS, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC has 39 stocks in it's portfolio. About 60.4% of the portfolio is in top 10 stocks. PCVX proved to be the most loss making stock for the portfolio. AADI was the most profitable stock for ACUTA CAPITAL PARTNERS, LLC last quarter.
Last Reported on: 14 Feb, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | aadi biosciences inc | 5.87 | 1,849,400 | 5,834,860 | unchanged | 0.00 | ||
| ACLX | arcellx inc | 0.83 | 10,743 | 823,881 | reduced | -82.7 | ||
| BNTC | benitec biopharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CDTX | cidara therapeutics inc | 1.47 | 54,473 | 1,464,230 | new | |||
| CELC | celcuity inc | 0.33 | 25,000 | 327,250 | reduced | -46.35 | ||
| CMPS | compass pathways plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRBP | corbus pharmaceuticals holdings | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRNX | crinetics pharmaceuticals in | 6.32 | 122,900 | 6,283,880 | reduced | -6.68 | ||
| CRVS | corvus pharmaceuticals inc | 0.40 | 74,307 | 397,542 | new | |||
| DYN | dyne therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ELDN | eledon pharmaceuticals inc | 0.98 | 235,750 | 971,290 | new | |||
| ELYM | climb bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| EWTX | edgewise therapeutics inc | 2.36 | 87,658 | 2,340,470 | added | 39.14 | ||
| FBRX | forte biosciences inc | 0.41 | 18,139 | 411,937 | new | |||
| GERN | geron corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GILD | gilead sciences inc | 0.85 | 9,150 | 845,186 | reduced | -53.08 | ||
| INSM | insmed inc | 7.28 | 104,800 | 7,235,390 | reduced | -2.51 | ||
| KURA | kura oncology inc. common stock | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| LPTX | leap therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| LQDA | liquidia corporation | 1.63 | 137,709 | 1,619,460 | added | 87.36 | ||